News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,744 Results
Type
Article (87511)
Company Profile (739)
Press Release (771478)
Multimedia
Podcasts (204)
Webinars (30)
Section
Business (232806)
Career Advice (4147)
Deals (39881)
Drug Delivery (147)
Drug Development (91207)
Employer Resources (205)
FDA (18277)
Job Trends (17429)
News (396948)
Policy (39853)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3008)
Academic (1)
Accelerated approval (35)
Adcomms (30)
Allergies (129)
Alliances (56794)
ALS (160)
Alzheimer's disease (1772)
Antibody-drug conjugate (ADC) (329)
Approvals (18394)
Artificial intelligence (495)
Autoimmune disease (175)
Automation (37)
Bankruptcy (402)
Best Places to Work (12512)
BIOSECURE Act (23)
Biosimilars (211)
Biotechnology (457)
Bladder cancer (150)
Brain cancer (53)
Breast cancer (551)
Cancer (4423)
Cardiovascular disease (312)
Career advice (3571)
Career pathing (42)
CAR-T (299)
CDC (38)
Celiac Disease (1)
Cell therapy (785)
Cervical cancer (30)
Clinical research (76302)
Collaboration (1672)
Company closure (4)
Compensation (1031)
Complete response letters (69)
COVID-19 (2933)
CRISPR (90)
C-suite (789)
Cystic fibrosis (143)
Data (5613)
Decentralized trials (2)
Denatured (75)
Depression (121)
Diabetes (348)
Diagnostics (7012)
Digital health (28)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (270)
Drug pricing (162)
Drug shortages (19)
Duchenne muscular dystrophy (207)
Earnings (98216)
Editorial (61)
Employer branding (25)
Employer resources (174)
Events (133176)
Executive appointments (860)
FDA (20736)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (25)
Funding (1325)
Gene editing (190)
Generative AI (50)
Gene therapy (622)
GLP-1 (947)
Government (5337)
Grass and pollen (4)
Guidances (277)
Healthcare (20792)
HIV (48)
Huntington's disease (49)
IgA nephropathy (82)
Immunology and inflammation (275)
Immuno-oncology (69)
Indications (100)
Infectious disease (3175)
Inflammatory bowel disease (213)
Inflation Reduction Act (14)
Influenza (105)
Intellectual property (209)
Interviews (817)
IPO (17813)
IRA (45)
Job creations (5200)
Job search strategy (2867)
JPM (68)
Kidney cancer (18)
Labor market (95)
Layoffs (641)
Leadership (39)
Legal (10094)
Liver cancer (88)
Longevity (16)
Lung cancer (607)
Lymphoma (340)
Machine learning (42)
Management (66)
Manufacturing (753)
MASH (163)
Medical device (14453)
Medtech (14486)
Mergers & acquisitions (22761)
Metabolic disorders (1097)
mRNA (195)
Multiple sclerosis (161)
NASH (22)
Neurodegenerative disease (345)
Neuropsychiatric disorders (83)
Neuroscience (2969)
Neurotech (1)
NextGen: Class of 2026 (7687)
Non-profit (5083)
Now hiring (68)
Obesity (541)
Opinion (333)
Ovarian cancer (153)
Pain (156)
Pancreatic cancer (180)
Parkinson's disease (268)
Partnered (33)
Patents (414)
Patient recruitment (453)
Peanut (58)
People (66420)
Pharmaceutical (133)
Pharmacy benefit managers (20)
Phase 1 (23653)
Phase 2 (33211)
Phase 3 (24866)
Pipeline (4732)
Policy (290)
Postmarket research (3544)
Preclinical (10607)
Press Release (72)
Prostate cancer (217)
Psychedelics (54)
Radiopharmaceuticals (288)
Rare diseases (841)
Real estate (7425)
Recruiting (81)
Regulatory (28390)
Reports (64)
Research institute (2702)
Resumes & cover letters (652)
Rett syndrome (21)
RNA editing (21)
RSV (67)
Schizophrenia (144)
Series A (236)
Series B (171)
Service/supplier (25)
Sickle cell disease (89)
Special edition (28)
Spinal muscular atrophy (175)
Sponsored (48)
Startups (4328)
State (2)
Stomach cancer (15)
Supply chain (75)
Tariffs (76)
The Weekly (127)
Vaccines (1030)
Venture capital (93)
Weight loss (348)
Women's health (77)
Worklife (22)
Date
Today (148)
Last 7 days (644)
Last 30 days (2198)
Last 365 days (25469)
2026 (3784)
2025 (25589)
2024 (34053)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (87)
Alaska (6)
Arizona (292)
Arkansas (9)
Asia (51192)
Australia (9012)
California (10065)
Canada (2539)
China (1088)
Colorado (316)
Connecticut (411)
Delaware (302)
Europe (117126)
Florida (1312)
Georgia (261)
Hawaii (4)
Idaho (65)
Illinois (668)
India (59)
Indiana (463)
Iowa (21)
Japan (359)
Kansas (135)
Kentucky (27)
Louisiana (14)
Maine (59)
Maryland (1289)
Massachusetts (7524)
Michigan (250)
Minnesota (458)
Mississippi (5)
Missouri (80)
Montana (29)
Nebraska (29)
Nevada (110)
New Hampshire (58)
New Jersey (2630)
New Mexico (29)
New York (2632)
North Carolina (1446)
North Dakota (9)
Northern California (4979)
Ohio (269)
Oklahoma (18)
Oregon (51)
Pennsylvania (1938)
Puerto Rico (23)
Rhode Island (35)
South America (1659)
South Carolina (14)
South Dakota (1)
Southern California (3882)
Tennessee (62)
Texas (1404)
United States (34880)
Utah (221)
Vermont (1)
Virginia (180)
Washington D.C. (54)
Washington State (835)
West Virginia (2)
Wisconsin (88)
859,744 Results for "remynd bio incubator wetenschapspark".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pfizer Becomes Newest Partner Added to BaseLaunch’s Biotech Venture Incubator
February 10, 2026
·
2 min read
Press Releases
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
December 12, 2025
·
7 min read
Press Releases
Viva Biotech’s invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
December 15, 2025
·
5 min read
Press Releases
Unlearn and remynd Partner on Alzheimer’s Study to Strengthen Confidence in Early Clinical Signals Using Digital Twins
April 3, 2025
·
2 min read
Press Releases
RFU Helix 51 Incubator Company Receives Illinois Innovation Voucher Grant Award for Cancer-Drug Development
January 7, 2026
·
1 min read
Press Releases
Precise Bio Announces Successful Transplantation of Additional Patients in Ongoing Clinical Study of 3D-Bio-Printed Corneal Implant
February 23, 2026
·
2 min read
Press Releases
Soligenix to Present at BIO Investment & Growth Summit
February 24, 2026
·
6 min read
Press Releases
Passage Bio to Participate in Upcoming Investor Conferences
February 19, 2026
·
1 min read
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
Regulatory documents show how 89bio’s board pushed Roche hard for a deal valued at $20 per share in upfront and milestone payments.
October 2, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
RESTEM to Present at BIO Investment & Growth Summit 2026
February 23, 2026
·
1 min read
1 of 85,975
Next
